CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Stelis Biopharma Names Mark W. Womack as its New CEO

Life Sciences Review Life Sciences Review | Monday, August 16, 2021
Tweet

Mark takes over as CEO immediately and will be based at the Stelis headquarters in Bengaluru, India.


FREMONT, CA: Stelis Biopharma Limited, a vertically integrated biopharma and vaccines Company and the biotech branch of Strides Pharma Science Limited, appoints Mark W. Womack (Mark) as its new Chief Executive Officer (CEO).


Mark is also the designated Managing Director (MD) and will subsequently be introduced to the board, subject to the requisite regulatory clearances and processes. Mark will provide strong leadership as the Company's CEO and MD, driving an aggressive growth and profitability strategy for Stelis in its business streams, including global Contract Development and Manufacturing Organization (CDMO) services and the development of the company's biosimilars pipeline, and integrated vaccines play. He will be in charge of the company's overall strategy and provide the essential direction and active leadership to R&D, manufacturing, business development, and commercial operations.


Commenting on the development, Arun Kumar, Founder, Strides Group, says, "We are delighted to onboard Mark as the new CEO of Stelis. Stelis stands on the cusp of a transition to become a globally recognized biopharmaceutical company while targeting significant growth in the coming years. Mark's strong background in commercial leadership, rich management consulting experience, and network within the biotech CDMO space make him exceptionally well suited to drive this transition for Stelis.  


We are confident that together Mark and his leadership team will take Stelis through the next level of growth, profitability and industry-leading reputation."


Mark is an organization builder who has a proven track record of producing remarkable performance and development in previous jobs. Before joining Stelis, Mark was the Chief Business Officer (CBO) for AGC Biologics (AGC), one of the world's largest global biopharmaceutical CDMOs. In his role at AGC, Mark oversaw a roughly threefold growth in new sales in just two years, as well as the acquisition of the majority of the world's top large pharma businesses. Mark previously supervised the global integration of three former CDMOs united to establish AGC Biologics, leveraging his management consultancy background.


Mark has over 25 years of experience as a management consulting industry leader and C-level client adviser, directing large-scale company transformations and guiding many of the world's most prestigious organizations to record highs in revenue and profit. During this time, he held the position of Chief Operating Officer for two worldwide management consulting firms.


Before joining the management consulting sector, Mark managed several US Navy units to unparalleled success, including serving as a battle center leader aboard a destroyer class ship. Mark is a US citizen located in Bengaluru, India, at the company's corporate headquarters.


Weekly Brief

loading
Top 10 Leading BioTech Solution Companies - 2021
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

Prophesying DNA Sequencing for 2023

Crucial Workflows of Next-Generation Sequencing

An Overview of Next-Generation Sequencing

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/stelis-biopharma-names-mark-w-womack-as-its-new-ceo-nwid-498.html